HELWAN UNIVERSITY
🇪🇬Egypt
- Country
- 🇪🇬Egypt
- Ownership
- Private
- Established
- 1975-01-01
- Employees
- 5K
- Market Cap
- -
- Website
- http://www.helwan.edu.eg
Long Term Follow up of Water Vapor Thermal Therapy (Rezum) for Benign Prostatic Hyperplasia (BPH)
Not Applicable
Completed
- Conditions
- Benign Prostatic HyperplasiaLower Urinary Track Symptoms
- Interventions
- Procedure: water vapor thermal therapy (Rezum) for prostate
- First Posted Date
- 2023-08-08
- Last Posted Date
- 2025-06-27
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 86
- Registration Number
- NCT05982444
- Locations
- 🇪🇬
Faculty of Medicine Helwan University, Helwan, Cairo, Egypt
The Effect of NAC in Decreasing the Incidence of Linezolid-induced Thrombocytopenia in Critically Ill Patients
- First Posted Date
- 2023-07-13
- Last Posted Date
- 2025-06-24
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 250
- Registration Number
- NCT05944458
- Locations
- 🇪🇬
15 May hospital, Cairo, Egypt
The Incidence of Linezolid-induced Thrombocytopenia (LIT) in Critically Ill Patients, the Risk Factors for LIT
- First Posted Date
- 2023-07-13
- Last Posted Date
- 2023-07-17
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 310
- Registration Number
- NCT05944445
- Locations
- 🇪🇬
15 May hospital, Cairo, Egypt
Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver Disease
- First Posted Date
- 2023-03-14
- Last Posted Date
- 2023-12-13
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 116
- Registration Number
- NCT05768334
- Locations
- 🇪🇬
National Hepatology and Tropical Medicine Research Institute, Cairo, Egypt
Prevention of Cefoperazone-induced Coagulopathy
- First Posted Date
- 2023-02-23
- Last Posted Date
- 2023-10-10
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 56
- Registration Number
- NCT05742295
- Locations
- 🇪🇬
6-October Hospital, Giza, Egypt
Colchicine Protective Effect in Patients Undergoing Percutaneous Coronary Intervention (COLCHICINE-PROTECT)
Phase 3
Recruiting
- Conditions
- Coronary Artery Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2023-02-22
- Last Posted Date
- 2023-03-22
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 400
- Registration Number
- NCT05739929
- Locations
- 🇪🇬
Helwan University Hospital, Helwan, Cairo, Egypt
Dapagliflozin in the Treatment of Heart Failure
Active, not recruiting
- Conditions
- Heart Failure
- First Posted Date
- 2023-02-14
- Last Posted Date
- 2024-01-29
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 45
- Registration Number
- NCT05727423
- Locations
- 🇪🇬
cardiology department at Ain Shams university hospitals, Cairo, Egypt
Biologics in Management of Inflammatory Bowel Disease in Egyptian Patients
Completed
- Conditions
- IBD
- First Posted Date
- 2023-02-09
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 100
- Registration Number
- NCT05720221
- Locations
- 🇪🇬
Faculty of pharmacy-Helwan University, Cairo, Egypt
Erythropoiesis Stimulating Agents for Anemia Management in Egyptian Hemodialysis Patients
Completed
- Conditions
- Anemia of Chronic Kidney DiseaseChronic Renal FailureChronic Renal Failure Anemia
- First Posted Date
- 2023-01-26
- Last Posted Date
- 2023-01-26
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 127
- Registration Number
- NCT05699109
- Locations
- 🇪🇬
the Memorial Souad Kafafi University Hospital, Giza, Egypt
NONSPECIFIC NECK PAIN
Not Applicable
Completed
- Conditions
- Non Specific Neck Pain
- Interventions
- Other: graston and muscle energy technique
- First Posted Date
- 2022-12-16
- Last Posted Date
- 2022-12-16
- Lead Sponsor
- Helwan University
- Target Recruit Count
- 42
- Registration Number
- NCT05654688
- Locations
- 🇪🇬
Helwan University, Cairo, Egypt